Giuliano La Fratta
Financieel Directeur/CFO bij AETERNA ZENTARIS INC.
Vermogen: - $ op 31-05-2024
Profiel
Giuliano La Fratta is currently the Chief Financial Officer & Senior Vice President at Æterna Zentaris, Inc. Prior to this, he was the Vice President-Finance at CellCarta Biosciences, Inc. He obtained his undergraduate degree from Concordia University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AETERNA ZENTARIS INC.
-.--% | 03-05-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Giuliano La Fratta
| Bedrijven | Functie | Begin |
|---|---|---|
| AETERNA ZENTARIS INC. | Financieel Directeur/CFO | 24-01-2022 |
Eerdere bekende functies van Giuliano La Fratta
| Bedrijven | Functie | Einde |
|---|---|---|
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Opleiding van Giuliano La Fratta
| Concordia University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AETERNA ZENTARIS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
